Joëlle Gaschet Selected Research

Joëlle Gaschet Research Topics

14	Neoplasms (Cancer) 02/2022 - 09/2011
7	Multiple Myeloma 06/2023 - 09/2013
3	Breast Neoplasms (Breast Cancer) 09/2011 - 01/2006
2	Residual Neoplasm 09/2020 - 09/2013
2	Adenocarcinoma 04/2014 - 01/2006
1	Melanoma (Melanoma, Malignant) 03/2021
1	Leukemia 03/2016
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2014
1	Neoplasm Metastasis (Metastasis) 10/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2014
1	Disease Progression 09/2013
1	Paralysis (Palsy) 09/2013
1	Triple Negative Breast Neoplasms 09/2011
1	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2011
1	Carcinogenesis 09/2009

5	Monoclonal AntibodiesIBA 11/2020 - 01/2006
2	Interleukin-2 (IL2)IBA 01/2022 - 01/2006
2	CytokinesIBA 01/2022 - 09/2009
2	Radioisotopes (Radionuclides)IBA 11/2020 - 10/2014
2	Neoplasm Antigens (Tumor Antigens)IBA 04/2016 - 01/2015
2	Bismuth-213IBA 01/2015 - 04/2014
1	Copper-64IBA 06/2023
1	Amino Acids FDA Link 02/2022
1	InterferonsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 03/2021
1	AntibodiesIBA 03/2021
1	B7-H1 AntigenIBA 03/2021
1	Therapeutic UsesIBA 03/2021
1	LigandsIBA 03/2021
1	elotuzumabIBA 09/2020
1	daratumumabIBA 09/2020
1	Astatine-211IBA 09/2020
1	CD66 antigensIBA 03/2016
1	Culture MediaIBA 01/2015
1	Lutetium-177IBA 01/2015
1	YttriumIBA 10/2014
1	AstatineIBA 10/2014
1	BismuthIBA 10/2014
1	IodineIBA 10/2014
1	LutetiumIBA 10/2014
1	Immunoconjugates (Immunoconjugate)IBA 10/2014
1	CD20 AntigensIBA 10/2014
1	Complement System Proteins (Complement)IBA 04/2014
1	Lenalidomide (CC 5013)FDA Link 09/2013
1	Thalidomide (Thalomid)FDA Link 09/2013
1	LuciferasesIBA 09/2013
1	Melphalan (Alkeran)FDA LinkGeneric 09/2013
1	Immunoglobulin G (IgG)IBA 09/2013
1	Hormones (Hormone)IBA 09/2011
1	AntigensIBA 09/2011
1	Syndecan-1 (Syndecan 1)IBA 09/2011
1	EpitopesIBA 05/2011
1	HLA-DPB1 antigen (HLA DPB1)IBA 05/2011
1	Interleukin-6 (Interleukin 6)IBA 09/2009
1	Trastuzumab (Herceptin)FDA Link 01/2006
1	Rituximab (Mabthera)FDA Link 01/2006